Atopic dermatitis (eczema) trials in Denmark

In Denmark 8 Also abroad 251

8 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Where
Copenhagen Nv, Odense C
Age
6 months to 11 years
People
195 worldwide
Run by
LEO Pharma
See details and how to joinNCT06311682 · EU 2023-503630-44-00
No phaseTaking people
Role of Interleukin-13 Pathways on Pain and Itch Sensitivity
Where
Aalborg, Gistrup
Age
18 years to 60 years
People
20
Run by
Aalborg University
See details and how to joinNCT06503510
Phase 3Not yet taking people in Denmark
A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis
Where
Aarhus N, Copenhagen Nv, Odense C
Age
12 years and over
People
230 worldwide
Run by
Almirall, S.A.
See details and how to joinNCT07873801 · EU 2025-525133-31-00
No phaseTaking people
Changes in Skin Myco- and Microbiome After Lebrikizumab Treatment
Where
Copenhagen
Age
18 years and over
People
60
Run by
University Hospital Bispebjerg and Frederiksberg
See details and how to joinNCT07807228
Phase 1Taking people
A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
Where
Herlev
Age
18 years to 65 years
People
149 worldwide
Run by
Sitryx Therapeutics Ltd
See details and how to joinNCT07558668
Phase 3Taking people
Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma
Where
Gentofte Municipality
Age
18 years to 45 years
People
2,000
Run by
Professor Klaus Bønnelykke
See details and how to joinNCT06560255
Phase 3Taking people
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
Where
Gentofte Municipality
Age
18 years to 45 years
People
2,000
Run by
Professor Klaus Bønnelykke
See details and how to joinNCT06570889
No phaseTaking people
A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis
Where
Aarhus
Age
18 years and over
People
1,000
Run by
Almirall, S.A.
See details and how to joinNCT06815380